Luis Martínez-Piñeiro (IdIPaz)

Our group, named UROBCG, is chaired by Dr Luis Martínez-Piñeiro and is dedicated mainly to clinical activity with patients. We all work in the urology department of La Paz University Hospital, in Madrid. Our main focus is to improve the diagnostic strategies of bladder and prostate cancer, either by using novel biomarkers or new optical systems with enhanced capabilities.

We are also involved in clinical trials and new therapeutic strategies that try to reduce the recurrence rate in non-muscle invasive bladder cancer. Optimization of immuno-oncologic treatments, such as BCG and its combination with the new immune check-point inhibitors are also an important area of clinical research.

Selected publications:

• E Ríos, L Martínez-Piñeiro. Nuevos quimioterápicos endovesicales y vehículos de aplicación. Arch Esp Urol. 2018; 71(4): 384-392.
• A Alcaraz, L Martínez-Piñeiro, A Rodríguez, J Rubio, Á Borque, J Burgos, J Carballido, JM Cózar, I Crespo, S Esquena, F Gómez-Veiga, D López, B Miñana, J Morote, MJ Ribal, E Solsona, JF Suárez. Consenso sobre el manejo del cáncer de próstata resistente a la castración avanzado en España. Arch Esp Urol. 2017 ; 70 :777-791 (Premio E.Pérez-Castro 2018, segundo finalista).
• A de la Taille, L Martínez-Piñeiro, P Cabri, A Houchard, J Schalken; Triptocare LT Study Group. Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy. BJU Int. 2017; 119(1): 74-81.
• L Martínez-Piñeiro, J Portillo, JM Fernández, J Zabala, I Cadierno, JL Moyano, E Solsona, M Unda, P Beardo, J Rodríguez-Molina, V Chantada, J Palou, P Muntañola, JM Alonso Dorrego, FJ Pérez-Garcia FJ, JM Silva, N Chesa, M Montesinos, A Ojea, R Madero, JA Martínez-Piñeiro. Maintenance therapy with 3-monthly Bacillus Calmette-Guérin for 3 years is not superior to standard induction therapy in high-risk non-muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO study 98013. Eur Urol. 2015; 68(2): 256-62.